กลุ่มอาการช่องคลอดหย่อนยาน is designated as the กลุ่มอาการของช่องคลอด characterized that the muscle located in vaginal cavity and vaginal opening area are loosened, the secretion of vaginal mucus is reduced and vaginal fascia is relaxed, and it frequently occurs after aging and childbirth, which may causes to the disadvantageous effect on rectum, uterus and bladder etc and it may exacerbate to occur serious problems, for example, fecal leakage, premature birth, stillbirth etc.
The representative phenomena of the disease are as follows: (1) the wind sound during sexual intercourse, (2) reduced frequency of orgasm feeling, (3) reduced sexual excitement caused by loosened vaginal muscle etc, which may be solved by various non-surgical therapy such as Kegel exercise well known as the pelvic muscle strengthening exercise to enforce pelvic muscle or surgical operation such as vaginal wall plastic operation for curing such worries but even if removing the loosened muscle with surgical operation, the muscle is not strengthened and have limited satisfaction. The vaginal mucus of woman is increased during sexually exciting period as follows: the volume of blood flow is increased to vaginal tunic and thereby blood plasma is exuded from submucus capillary blood vessel. โคลโพซีโรซิส occurs by the reduced level of estrogen hormone before or after menopause and is characterized with the little secretion of vaginal fluid and reduced leukorrhea in spite of sexually excited period, which gives rise to various problems in conjugal sexual life, for example, vaginitis, vulvar or vaginal itching, dyspareunia, vaginismus postcoital spotting, dysuria, hematturia, severe pain caused by uterine contraction during or after orgasm, lower abdominal pain, the frequent occurrence of dysmenorrhea, vaginitidis, etc.
There have been still needed to develop effective therapies to treat กลุ่มอาการช่องคลอดหย่อนยาน or โคลโพซีโรซิส disease, effectively and safely till now.
Accordingly, there has been needed to develop novel therapeutic composition showing long-term treating activity with safety to treat กลุ่มอาการช่องคลอดหย่อนยาน or โคลโพซีโรซิส disease.
However, there has been not reported or disclosed on the therapeutic effect for กลุ่มอาการช่องคลอดหย่อนยาน or โคลโพซีโรซิส disease of the combination of salt and sugar in any of the above cited literatures, the disclosures of which are incorporated herein by reference.
To investigate an inhibitory effect of the combination of salt and sugar on กลุ่มอาการช่องคลอดหย่อนยาน or โคลโพซีโรซิส disease, the inventors of the present invention have carried out various experiments, for example, vaginal smooth muscle contractility test using by New Zealand White Rabbit; (Experimental example 1); the effect on the vagina contractility in volunteers by using perinometer (Experimental example 2); and the effect on the โคลโพซีโรซิส disease in volunteers (Experimental example 3) and finally completed present invention by confirming that the combination showed improving effect on the contractility of vagina tissue and โคลโพซีโรซิส disease in the test.
These and other objects of the present invention will become apparent from the detailed disclosure of the present invention provided hereinafter.
[Disclosure]
[Technical Problem]
The present invention relates to a skin external composition comprising a salt and sugar as active ingredients for preventing and treating กลุ่มอาการช่องคลอดหย่อนยาน or โคลโพซีโรซิส disease and the use thereof.
The present invention relates to a use of the ของผสม of a salt and sugar in the manufacture of a medicament employed for treating กลุ่มอาการช่องคลอดหย่อนยาน or โคลโพซีโรซิส disease in a สัตว์เลี้ยงลูกด้วยนม.
[Technical Solution]
Accordingly, it is another object of the present invention to provide an external composition comprising a combination of salt and sugar as an active ingredient in an amount effective to treat or prevent กลุ่มอาการช่องคลอดหย่อนยาน or โคลโพซีโรซิส disease, together with a pharmaceutically acceptable carrier.
It is another object of the present invention to provide a use of a combination of salt and sugar in the manufacture of a medicament employed for treating or preventing กลุ่มอาการช่องคลอดหย่อนยาน or โคลโพซีโรซิส disease in a สัตว์เลี้ยงลูกด้วยนม.
It is the other object of the present invention to provide a method of treating or preventing กลุ่มอาการช่องคลอดหย่อนยาน or โคลโพซีโรซิส disease in a สัตว์เลี้ยงลูกด้วยนม wherein method comprises administering to said สัตว์เลี้ยงลูกด้วยนม an effective amount of a combination of salt and sugar, together with a pharmaceutically acceptable carrier thereof.
In one embodiment of the present invention, the present invention provides an external composition comprising a combination of salt and sugar as an active ingredient in an amount effective to treat or
prevent กลุ่มอาการช่องคลอดหย่อนยาน or โคลโพซีโรซิส disease, together with a pharmaceutically acceptable carrier.
Additionally, the present invention provides a use of a combination of salt and sugar in the manufacture of a medicament employed for treating or preventing กลุ่มอาการช่องคลอดหย่อนยาน or โคลโพซีโรซิส disease in a สัตว์เลี้ยงลูกด้วยนม.
Additionally, the present invention provides a method of treating or preventing กลุ่มอาการช่องคลอดหย่อนยาน or โคลโพซีโรซิส disease in a สัตว์เลี้ยงลูกด้วยนม wherein method comprises administering to said สัตว์เลี้ยงลูกด้วยนม an effective amount of a combination of salt and sugar together with a pharmaceutically acceptable carrier thereof.
The term, "salt' defined herein comprise a processed salt such as melted salt or an un-refined salt such as sea salt, rock-salt etc, preferably, a refined salt such as sodium chloride or melted salt such as bamboo salt, more preferably, a melted salt prepared by melting a un-refined salt at the
temperature ranging from 200 to 2000°C, preferably, from 800 to 1200°C, for the period ranging from
2 hours to 7 days, preferably, 12 hours to 48 hours.
The term, "sugar' defined herein comprise a saccharide compound, preferably, mono-saccharides such as glucose, fructose, mannose, galactose, etc or disaccharides such as lactose, maltose, sugar, etc, more preferably, glucose, more preferably, crystalline glucose.
The term, "a combination of salt and sugar' defined herein comprise a combination of salt and sugar mixed ratio of 1: 1-30 (w/w , preferably, 1: 1-10 (w/w), more preferably, 1: 1-5 (w/w), most preferably, 1: 1-3 (w/w).
The composition of the present invention may further contain the other antibiotics, dye, flavor etc in the amount of about 0.1 - 20 % by weight of the above composition based on the total weight of the composition.
Hereinafter, the present invention is described in detail.
An inventive composition comprising the combination of salt and sugar can be prepared in detail by following procedures.
For example, the inventive cleansing combination of the present invention can be prepared by follows; an un-refined salt such as sea salt, rock-salt etc is melted at the temperature ranging from 200 to
2000°C, preferably, from 800 to 1200°C, for the period ranging from 2 hours to 7 days, preferably, 12 hours to 48 hours to obtain the melted salt at the 1st step; the melted salt is mixed with sugar compound, preferably, mono-saccharides such as glucose, fructose, nnannose, galactose, etc or disaccharides such as lactose, maltose, sugar, etc, more preferably, glucose, more preferably, crystalline glucose with mixed ratio of 1: 1-30 (w/w , preferably, 1: 1-10 (w/w , more preferably, 1: 1-5 (w/w), most preferably, 1: 1-3 (w/w) to obtain inventive combination; and the combination is dissolved in an appropriate amount of distilled water, buffer, or isotonic solution, if necessary, with an
appropriate amount of the other additives such as the other antibiotics, dye, flavor etc to obtain the inventive cleansing composition.
Accordingly, in an another embodiment of the present invention, the present invention provides a method for preparing the inventive cleansing combination comprising the step: of a processed salt such as melted salt or an un-refined salt such as sea salt, rock-salt etc at the temperature ranging
from 200 to 2000°C, preferably, from 800 to 1200°C, for the period ranging from 2 hours to 7 days, preferably, 12 hours to 48 hours to obtain the melted salt at the 1st step; mixing the melted salt with sugar compound, preferably, mono-saccharides such as glucose, fructose, nnannose, galactose, etc or disaccharides such as lactose, maltose, sugar, etc, more preferably, glucose, more preferably, crystalline glucose with mixed ratio of 1: 1-30 (w/w), preferably, 1: 1-10 (w/w), more preferably, 1: 1-5 (w/w), most preferably, 1: 1-3 (w/w) to obtain inventive combination; and dissolving the combination in an appropriate amount of distilled water, buffer, or isotonic solution, if necessary, with an appropriate amount of the other additives such as the other antibiotics, dye, flavor etc to obtain the inventive cleansing composition.